0000000001215970

AUTHOR

Evgeniy Perlov

showing 2 related works from this author

Frontocingular Dysfunction in Bulimia Nervosa when Confronted with Disease-specific Stimuli

2011

Objective Bulimia nervosa (BN) is characterized by dysregulation of impulse control, in other words, uncontrolled eating. Functional neuroimaging studies have been sparse and have used variable methodologies. Method Thirteen medication-free female BN patients and 13 female healthy controls were investigated by functional magnetic resonance imaging using a disease-specific food paradigm. Stimuli were rated after the scanning procedure. Results Bulimia nervosa patients showed increased fear ratings and a trend for increased disgust. Magnetic resonance imaging data of 10 BN patients could be analysed. Three BN patients had to be excluded from the analysis because of minimal blood oxygen level …

Cingulate cortexmedicine.medical_specialtyBlood-oxygen-level dependentmedicine.diagnostic_testBulimia nervosaAudiologymedicine.diseaseTemporal lobePsychiatry and Mental healthClinical PsychologyEating disordersmedicine.anatomical_structureFunctional neuroimagingmedicinePsychologyFunctional magnetic resonance imagingPsychiatryAnterior cingulate cortexEuropean Eating Disorders Review
researchProduct

Effects of Group Psychotherapy, Individual Counseling, Methylphenidate, and Placebo in the Treatment of Adult Attention-Deficit/Hyperactivity Disorder

2015

Importance Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder with high prevalence in adulthood. There is a recognized need to assess the efficacy of psychotherapy in adult ADHD. Objective To evaluate the efficacy of cognitive behavioral group psychotherapy (GPT) compared with individual clinical management (CM) and that of methylphenidate hydrochloride compared with placebo. Design, Setting, and Participants Prospective, multicenter, randomized clinical trial of 18- to 58-year-old outpatients with ADHD from 7 German study centers. Patients were recruited between January 2007 and August 2010, treatment was finalized in August 2011, and final follow-up assessmen…

medicine.medical_specialtyPediatricsMethylphenidatemedicine.medical_treatmentMedizinmedicine.diseasePlacebo030227 psychiatry3. Good healthlaw.inventionGroup psychotherapyCognitive behavioral therapy03 medical and health sciencesPsychiatry and Mental health0302 clinical medicineRandomized controlled triallawClinical Global ImpressionmedicineAttention deficit hyperactivity disorderMethylphenidate HydrochloridePsychiatryPsychology030217 neurology & neurosurgerymedicine.drugJAMA Psychiatry
researchProduct